Metagenomi Therapeutics, Inc. (MGX)
1.63
+0.02
(+1.24%)
USD |
NASDAQ |
Jan 21, 16:00
1.67
+0.04
(+2.45%)
After-Hours: 20:00
Metagenomi Therapeutics Market Cap: 61.20M for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ionis Pharmaceuticals, Inc. | 12.87B |
| AnaptysBio, Inc. | 1.292B |
| Ovid Therapeutics, Inc. | 116.08M |
| Nutriband, Inc. | 55.43M |
| Cogent Biosciences, Inc. | 6.126B |
Market Cap Related Metrics
| PS Ratio | 1.963 |
| Price to Book Value | 0.3430 |
| Price | 1.63 |
| Earnings Yield | -146.2% |